• Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Please share this website:

    South Australia - Other

    Every day researchers work towards finding new breakthroughs in cancer. Clinical trials play a pivotal role in bringing that defeat closer.

    Clinical trials test promising new treatments on people to see if they are better than existing cancer treatments. The trial process is long starting many years before an actual treatment can be used.

    By joining a clinical trial you are helping to create new breakthroughs in cancer research. Hundreds of thousands of people all over the world have taken part in clinical trials that have lead to safer and more effective treatments for many cancers.

    It is important to note that not all cancer patients are eligible to take part in clinical trials and there are not clinical trials for all types of cancer.

    You may decide to join a clinical trial because:

    • The treatment you receive will be at least the best available for your illness.
    • Your health may improve because of the treatment you receive.
    • You may receive a treatment you would not otherwise have access to.
    • Your health will be carefully checked by the treatment team running the trial.
    • You will be part of the worldwide effort to improve cancer treatment.

    For more information on clinical trials please click here.

    Clinical trial managers:

    If you would like information regarding any of the below clinical trials, please contact the appropriate Clinical trials manager:

    Ashford Cancer Centre: Helen Daykin, +61 8 8292 2240

    Flinders Medical Centre: Alex Scott-Hoy, +61 8 8204 4830

    The Queen Elizabeth:  Sue Yeend, +61 8 8222 6148

    Lyell McEwin Hospitals: Julie Rowe or Rohit Joshi +61 8 8282 0833

    Royal Adelaide Hospital: Anne Milton, +61 8 7074 2342

    Current clinical trials for other cancer

    Status Description Organisation
    Recruiting 15.03 (Fastrack II) Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney - A Phase II Clinical Trial Royal Adelaide Hospital
    Not yet recruiting ACTICCA-1 Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gall bladder carcinoma Flinders Medical Centre
    Recruiting ARRAY BEACON Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5- Fluorouracil (5-FU)/Folinic Acid (FA) /Irinotecan (FOLFIRI)/Cetuximab with a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients with BRAF V600E- mutant Metastatic Colorectal Cancer Flinders Medical Centre
    Recruiting Phase I open label trial of Abraxane (nab-paclitaxel) administered concurrently with Radiotherapy in patients with locally advanced inoperable pancreatic adenocarcinoma Flinders Medical Centre
    Recruiting BGB A317 BeiGene's Phase 1, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics and Antitumor Activities of the anti-PD-1Monoclonal Antibody BGB-A317 in Subjects with Advanced Tumors Royal Adelaide Hospital
    Recruiting BGB-A317_Study_001 A Phase 1, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics and Antitumor Activities of the anti-PD-1 Monoclonal Antibody BGB-A317 in Subjects with Advanced Tumors The Queen Elizabeth Hospital
    Recruiting CA209-577 Randomized, Multicenter, Double blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction cancer. Royal Adelaide Hospital
    Not yet recruiting CANSTEM BBI608 A Phase III Study of BBI-608 in combination with 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients with Previously Treated Metastatic Colorectal Cancer (CRC). Flinders Medical Centre
    Recruiting ELD15 - An international field study of the reliability and vailidity of an eortc older-specific quality of life (QOL) questionnaire module (the eortc QLQ-ELD15) and eortc QLQ-C30 in assessing the QOL of cancer patients aged 70 years and above Royal Adelaide Hospital
    Recruiting EMR200647‐001 A Phase I, open‐label, multiple‐ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0011359C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications The Queen Elizabeth Hospital
    Recruiting FIG Efficacy and safety of FOLFIRINOX as Neoadjuvant chemotherapy for resectable gastric or gastroesophageal junction adenocarcinoma: A Run-In Pilot followed by Phase 2 comparison between ECF and FOLFIRINOX – FIG Study Royal Adelaide Hospital
    Not yet recruiting GLANCE Global Treatment Patterns, Health Care Resource Utilization, and Survival Outcomes among Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Flinders Medical Centre
    Recruiting HPV Oropharynx A Randomised Trial of Weekly Cetuximab and 408.14 1 Radiation versus Weekly Cisplatin and Radiation in Good Prognosis Locoregionally Advanced HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV OROPHARYNX) Flinders Medical Centre
    Recruiting InterAACT An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin plus 5-fluorouracil versus Carboplatin plus Weekly Paclitaxel in Patients with Inoperable Locally Recurrent or Metastatic Disease Flinders Medical Centre
    Recruiting Randomised, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo plus Cisplatin and Gemcitabine as First-line treatment in patients with Advanced or metastatic Biliary Tract Cancer Royal Adelaide Hospital
    Recruiting Keynote -522 A Phase III randomized, double-blind study to evaluate Pembrolizumab plus chemotherapy vs placebo plus chemotherapy as neoadjuvant therapy and pembrolizumab vs placebo as adjuvant therapy for TNBC Royal Adelaide Hospital
    Recruiting A Randomised Phase III study of pembrolizumab given concomitantly with chemoradiation and as maintenance therapy versus chemoradiation alone in subjects with locally advanced H&N SCC. Royal Adelaide Hospital
    Recruiting NIMO - Phase 2, double-blind, placebo-controlled study of post-operative adjuvant concurrent chemo-radiotherapy with or without nimotuzumab for stage 3 or 4 head and neck squamous cell cancer Flinders Medical Centre
    Recruiting QB46C-H02. Phase I Dose-Escalation Study to determine the Safety and Tolerability of an Intratumoural Injection of EBC-46 in Patients with Refractory Cutaneous or Subcutaneous Tumours Flinders Medical Centre
    Not yet Recruiting S-AVANT S-AVANT C13-1 Follow up to the AVANT study at 8 and 10 years (median follow-up in patients with carcinoma Flinders Medical Centre
    Recruiting SPIT - Saliva used as a prognostic indicator in treatment Flinders Medical Centre
    Recruiting XL184-401 A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Cabozantinib (XL184) at 60mg/Day Compared to 140mg/Day in Progressive, Metastatic Medullary Thyroid Cancer Patients Ashford Cancer Centre Research

    Today at Cancer Council SA

  • Become an Ambassador

    Become an Ambassador

    Join our growing network of Ambassadors who represent us in the community: sharing awareness and prevention messages, connecting people with support services and speaking up on our behalf.

  • Call Quitline 13 7848 to double your chances of quitting

    Call Quitline 13 7848 to double your chances of quitting

    Quitline is a confidential and professional support service that can assist you to work out your quitting strategy. Register today!

  • Cancer Council SA Election Priorities

    Cancer Council SA Election Priorities

    Cancer Council SA’s 2018 Election Priorities document urges the South Australian Government to make nine key legislative changes in the 2018.

  • Do you have a cancer question?

    Do you have a cancer question?

    Ask our trained cancer nurses for the answers.

  • Healthy Living after Cancer

    Healthy Living after Cancer

    Getting back to a healthy lifestyle after cancer is one of the most important things you can do for your health. Find out about our Healthy Living after Cancer program.

  • Heard something about cancer and not sure if it's true?

    Heard something about cancer and not sure if it's true?

    Get all the evidence based answers to your cancer questions here.

  • Help us continue supporting South Australian families impacted by cancer.

    Help us continue supporting South Australian families impacted by cancer.

    Gina Rositano was surrounded by loved ones when she received the devastating prognosis of 18 months to live, due to the discovery of stage four glioblastoma, a type of fast-growing brain tumour.

  • Hold your own fundraiser

    Hold your own fundraiser

    Do you have an idea that is out of the box? Do you think it rocks? You can turn virtually anything into a fundraiser… let us help you turn your idea into reality!

  • Join the conversation

    Join the conversation

    Follow us on Facebook to stay up to date with the latest community events and news.

  • Meet a researcher

    Meet a researcher

    If Professor Howarth’s project is a success, not only will a lot of people be spared a lot of pain. Lives will be saved as a result of treatments continuing that would otherwise have been stopped prematurely. Read more.

  • More than a gift, it's hope for the future

    More than a gift, it's hope for the future

    Including a bequest to Cancer Council SA in your will is not an alternative to looking after your loved ones, it’s part of it. Find out more.

  • Order resources here

    Order resources here

    Cancer information and support resources are provided free of charge to all people affected by cancer.

  • Share your story

    Share your story

    Raise awareness about important cancer issues and help others cope with treatment and feel less alone. Read more about how to share your story.

  • Sophie's cancer story

    Sophie's cancer story

    Sophie Hughes has endured the ongoing struggle of seeing so many of her loved ones go through cancer diagnoses.

  • SunSmart: It all adds up

    SunSmart: It all adds up

    Anywhere you go, UV will damage unprotected skin—and it just keeps adding up.